Top Stock Picks This Week: AIICO, Ikeja Hotel & Fidson Lead as Investors Eye Dividend Plays

[John Esther]

@Little Princess :This is the shift many overlooked for years.
AIICO Insurance Plc isn’t just growing premiums—the 41.7% dividend jump to ₦0.12 is a clear signal of strong earnings and improving cash flow.
In a high MPR environment, insurers quietly benefit from:
Higher yields on their investment portfolios
Steady premium income growth
Potential re-rating from undervalued levels

The real edge now is identifying which insurers can sustain both growth and payouts.

Insurance is no longer “slow money”—it’s becoming a value + income play for patient investors

Exactly! AIICO’s 41.7% dividend increase shows real earnings strength, not just a headline number. In this high-rate environment, insurers like AIICO benefit quietly from higher investment yields and steady premium growth. The key now is spotting which ones can sustain both growth and dividends—insurance is turning into a solid value + income play for patient investors.

 

[Chinyere]

This is a solid setup for the week—quiet market, but smart money is already positioning.
AIICO Insurance Plc and Custodian Investment Plc look like the cleaner dividend/value plays, while Fidson Healthcare Plc leans more toward growth with higher expectations already priced in. Ikeja Hotel Plc sits somewhere in between with improving numbers.
Overall, this week feels less about chasing moves and more about positioning early—especially ahead of bank earnings.

Yep, this week is about positioning and less of chasing moves

 

[Chinyere]

F

That makes sense. Accumulating Fidson Healthcare Plc after the dividend payout is a smart move—prices often cool off post-dividend, giving better entry.
The bigger story is still intact: strong earnings growth, expanding capacity, and a solid position in the pharma space. If they keep executing like this, it’s definitely one of the names to watch both now and going forward.

Fidson is a stock to watch as it has both strong earnings and expansion capacity

 

[Chinyere]

Yes ohh, you're right, they still have, it's to select amongst and hold

I agree with you

 

[Chinyere]

Exactly. The edge now is going beyond dividends—checking if the payout is sustainable and whether the stock is still undervalued. Smart money isn’t chasing yields blindly; it’s quietly positioning ahead of earnings while rotating into quality names that the market hasn’t fully priced yet.

Absolutely. The real advantage comes from assessing dividend sustainability and underlying value. Following smart money into quality names before the market fully prices them can yield bigger, more reliable gains than chasing yields alone.

 

[Chinyere]

That’s a solid way to look at it. Waiting till after the dividend helps you avoid the usual price drop, and with Fidson Healthcare Plc already priced for growth, the real focus is whether earnings can keep up with that expectation. If they keep delivering, gradual accumulation makes sense—just stay disciplined with your entries.

Timing around the ex-dividend period avoids the short-term drop, and the key is confirming that Fidson’s earnings keep pace with market expectations. Gradual, disciplined accumulation lets you ride the growth without overpaying.

 

[Chinyere]

Exactly. Insurance stocks may not move fast, but with low valuations and improving fundamentals, they quietly compound over time. For patient investors, those steady, under-the-radar gains can add up nicely.

Low P/E insurance stocks with improving fundamentals are the classic slow-and-steady compounders. Patience here often turns into meaningful long-term rewards.

 

[Chinyere]

Exactly. That’s where the edge is, quietly sitting in undervalued names. Custodian Investment Plc at that valuation and dividend isn’t just cheap, it reflects strong cash flow and confidence.

While everyone focuses on the big banks, these steady compounders often deliver both income and re-rating over time.

Custodian’s combination of a low P/E and rising dividend shows real financial strength. Quietly holding these undervalued compounders can be just as rewarding—sometimes even more—than chasing the obvious big-cap names.

 

[Chinyere]

that’s smart. Waiting until after the ex-dividend dip lets you buy at better value. Fidson Healthcare Plc still stands out for growth and sector positioning, even at a premium. Timing matters: buy on weakness, hold for the long-term story.

Using the ex-dividend dip as an entry point lets you capture Fidson’s growth story at a slightly better price. Patience and disciplined timing amplify the long-term gains while staying exposed to the sector’s upside.